Resumption of Prescribing Saxenda for Obesity Treatment

Saxenda (GLP-1 injection medicine)

We are pleased to announce that as of today, we will be resuming the prescription of the obesity treatment medication, “Saxenda”.

Please note that the obesity treatment medication “Ozempic” has been discontinued since September of this year due to uncertain availability. If you are currently using Ozempic, we recommend considering either Saxenda or the oral medication “Rybelsus”.

関連ページ-Related Pages-

Let's share this post !